ADMA Biologics Inc - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADMA Nasdaq 2836 https://www.admabiologics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADMA Biologics Inc

ADMA Biologics Granted U.S. Patent for Treatment and Prevention of Pneumococcal Infections - Apr 17th, 2019 5:08 am
ADMA Biologics: Wall Street Projects Robust Revenue Growth - Apr 3rd, 2019 3:00 pm
Why ADMA Biologics Stock Soared Yesterday - Apr 3rd, 2019 1:27 pm
The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings - Apr 3rd, 2019 6:19 am
ADMA Receives Department of Health and Human Services U.S. License - Apr 2nd, 2019 4:58 pm
ADMA Biologics Rips Higher On FDA Nod For Immunodeficiency Therapy - Apr 2nd, 2019 8:26 am
ADMA Biologics' stock rockets on heavy volume after FDA approval of immunodeficiency treatment - Apr 2nd, 2019 7:00 am
The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial - Apr 2nd, 2019 5:30 am
FDA Approves ASCENIV™, a Novel Intravenous Immune Globulin - Apr 1st, 2019 6:09 pm
Adma Biologics: 4Q Earnings Snapshot - Mar 13th, 2019 6:19 pm
ADMA Biologics Reports Full Year 2018 Financial Results - Mar 13th, 2019 3:05 pm
ADMA Biologics to Present at Upcoming Investor Conferences - Feb 25th, 2019 5:38 am
Watch These Tech Stocks Set The Pace On Tuesday 2/12/19 - Feb 12th, 2019 10:30 am
ADMA Biologics Enters Into $72.5 Million Loan Facility with Perceptive Advisors - Feb 12th, 2019 5:38 am
ADMA Biologics Submits Response and Provides Supplemental Information to FDA for BIVIGAM® Complete Response Letter - Jan 7th, 2019 5:08 am
Have Insiders Been Buying ADMA Biologics, Inc. (NASDAQ:ADMA) Shares This Year? - Dec 26th, 2018 9:40 am
Here is What Hedge Funds Think About ADMA Biologics Inc (ADMA) - Dec 23rd, 2018 5:25 am
Here's Why ADMA Biologics Is Getting Hammered Today - Dec 20th, 2018 4:20 pm
ADMA to Host Conference Call to Discuss Recent Regulatory Update on BIVIGAM® PAS Submissions - Dec 20th, 2018 4:08 am
FDA declines to approve re-launch of ADMA Biologics' Bivigam - Dec 19th, 2018 4:36 pm